Who to call at uniQure N.V., and when
Fundz watches for the moments uniQure N.V. starts buying, and tells you who to reach.
- An alert the day uniQure N.V. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at uniQure N.V., from your own LinkedIn network
uniQure N.V.
The company shared information publicly (Regulation FD). An 8-K is the notice a US public company must file within four business days of a major event.
www.uniqure.comAI Executive Summary
AI-powered analysis of 8-K filing content
uniQure N.V. provided a clinical update on its AMT-130 program on September 29, 2026, sharing advancements in ongoing clinical trials through a presentation and press release. This disclosure informs stakeholders of R&D progress that may influence investor perception and stock valuation.
Key Takeaways
uniQure presented significant advancements in AMT-130 clinical development on September 29, 2026
The update was disseminated via both presentation and press release to inform shareholders and the market
2 more takeaways
Filing Overview
What This Means
uniQure N.V. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.